New University of Michigan Tinnitus Discovery — Signal Timing

Has anyone seen any info on how Dr. Shore's treatment will be offered?

I read somewhere that she hopes “eventually” to offer home-usage devices but have not seen anything about where the treatment will be available before that. I’m sure they will be very expensive but I’ll sell all my children and cats to be able to buy one... well maybe just the children...

 

I'd go with the incompetence explanation over patent avoidance.

 

But the other thing with Dr. Shore’s device is that it isn’t administered through the tongue so who knows if the same timings would apply.

 

Capitalism at its best.

 

.

 

The truthful thing is that although this is an example of capitalism and capitalistic business practices, it is inevitably going to yield the best outcome. If Dr. Shore hypothetically merged her device into another device like Lenire, then there can be the possibility that not only would she lose the benefit from what she has spent years working on but she would also possibly lose control over treatment which would mean that she is effectively facing the distinct possibility of not actually also being able to release the device that she wants to. This therefore may mean that her signal timings in another device like Lenire would provide to be inferior in some way.

 

This bushy cell thing is new. Wonder how that was determined. Good to see more independent confirmation that the issue lies in inflammation/synapse damage somewhere between the cochlea and the auditory nerve. Does this information change anything about which current or upcoming medications/supplements/lifestyles might be most effective?

 

Along with the delay in Dr. Shore's work due to COVID-19, I have been concerned about any additional delays in tailoring her device for market.

When approached, Dr. Shore has stated that they are developing the commercial version of their device before the end of the trial. Her words were 'we are working on it'.

I believe she has filed for patents in Europe and Australia, which may have been approved?

The plan is to release it worldwide, but I'm unsure if it has been approved internationally yet.

 

Interesting. My understanding is that commercialisation will be handled by a dedicated department not directly connected to her lab. Maybe it's time to approach them to see if we can glean a little more information?